Pamlab headquarters is located in Covington, Louisiana. The company has been in the pharmaceutical industry since 1957, over 50 years. Initially, the company introduced numerous prescription cough/cold products to prescribing physicians in Louisiana.
In 1987, the company was purchased by Samuel and Judith Camp, who recognized the need for product line expansion and professional field sales force. Over the next 10 years, the Covington, Louisiana based Pan American Laboratories grew substantially and profitably, becoming a trusted name among thousands of physicians throughout the Southeast.
Pamlab is now a fully integrated pharmaceutical company, with approximately 300 employees, specializing in prescription medical foods. Pamlab products are marketed and sold nationally.
Pamlab expanded to include: Pan American Laboratories and Red River Pharma.
In 2013, Pamlab was acquired by Nestlé Health Science as part of a global strategic business plan to serve patients with a new approach to healthcare products and services. NHSc works to provide nutritional solutions based upon clinical evidence to manage to better health outcomes. The acquisition of Pamlab into this vision was a very good strategic fit and immediately added value for both patients and physicians in the studies of metabolic health and brain health.
We proudly offer a comprehensive and valuable benefits package designed to fit the needs of our employees and their families. Learn More...
Pamlab Announces Agreement for Sale of Business to Nestlé Health Science. Acquisition Adds Value to Patients and Healthcare Providers in Brain Health and Metabolic Health.
Dr. Vivian Fonseca and Dr. John Anderson conducted a CME for Medscape on the benefits of Metanx® therapy.
Metanx® clinical data is published in The American Journal of Medicine. Dr. Vivian Fonseca is the primary investigator of the study.
2013 annual National Sales Meeting for all Pamlab employees and sales force was held in New Orleans, LA.
Deplin® is featured in research by Dr. George Papakostas (Mass General Hospital) research on L–methylfolate. The article is written by Dr. Drew Ramsey of Columbia University
L–methylfolate research by Dr. George Papakostas (Mass General Hospital) and Dr Richard Shelton (Univ S Alabama) and Dr. John Zajecka (Rush University) has been published.
Dr. Chuck Raison (AZ), Dr. Vladimir Maletic (SC) and Dr. Rakesh Jain (TX) lead a CME course on L–methylfolate at U.S.P.C. in San Diego.
Dr. Andy Cutler (FL) lead a Deplin® Product Theater at NEI Conference in San Diego.
Metanx®Clinical Study has been published in the current issue of AJPB. This pharmacoeconomics study was conducted by Rolin Wade RPh, from Cerner LifeSciences of Beverly Hills will be of interest to managed care organizations.
CerefolinNAC® sponsored the AA Walk for the LA Chapter in Fontainebleau State Park.
Pamlab served as a major corporate sponsor for the inaugural ADA walk of the Northshore, LA chapter in Mandeville, LA.
Discovery Channel Profile Series featured CerefolinNAC® doctors and patients speaking about the product. National television broadcast and web channel broadcast.
CerefolinNAC® was a national corporate attendee at AARP National Conference in New Orleans.
Pamlab employees elected mid–year VERITAS award winners for company town hall meeting. Role model employees were recognized in 8 categories.
Metanx® clinical data is published regarding positive research. The research was conducted at the Pennington Research Center by Irina Obrosova, PhD.
A national webinar on Metanx® hosted by Dr. Allen Jacobs (MO) and Dr. Todd Levine (AZ).
Deplin® poster on new clinical data published at APA conference in Philadelphia.
National thought leaders Deborah Hinnen (KA) and Virginia Valentine (NM) led online webinar of Metanx®.
Pamlab, Inc launches the LESS IS MORE initiative to initiate the use of digital detailing with outside sales reps and internet marketing initiatives. App development and data mart management will be done in-house.
Deplin® sponsored a national DSA program entitled "Beyond the Resistance" to educate physicians on their options for difficult patients who do not adequately respond to their initial therapy. The national initiative will take place in 38 cities over the course of six months.
Dr. Emily Clinonsky (MA) was a featured speaker for CerefolinNAC® in Washington DC.
2012 annual National Sales Meeting for all Pamlab employees and sales force was held in Dallas, TX.
Wall Street Journal published a long format article on Deplin® in the January 3 issue."
Employee Open Enrollment for Benefits
Christmas Angel Tree Project
Employee Stock Ownership Program (ESOP) Celebration
Operation Gratitude Project
New Sales Training Class
Pamlab Hosts Blood Drive
Brand Direct Health Began Verifying Patient Insurance Coverage
Brand Direct Health Moved Into New Facility